Respiratory syncytial virus Clinical Trials in Chengdu, Sichuan
4 recruitingChengdu, Sichuan, China
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease
Respiratory Syncytial Virus Infections
GlaxoSmithKline750 enrolled13 locationsNCT07220109
Recruiting
Phase 3
A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children
Respiratory Syncytial Virus Infection
Simcere Pharmaceutical Co., Ltd498 enrolled4 locationsNCT07402512
Recruiting
Phase 3
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)
Respiratory Syncytial Virus (RSV)
MAXVAX Biotechnology Limited Liability Company25,000 enrolled8 locationsNCT07272434
Recruiting
Not Applicable
Peginterferon α-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus Pneumonia
Respiratory Syncytial Virus (RSV)
West China Second University Hospital90 enrolled2 locationsNCT06881056